Searched for
PATENT GROWTH IN DIAGNOSTICS
These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 24%When business updates start to come in or when some FMCG or auto companies indicate that things are not all good in the rural space, we may...- Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...
- Not all startups are built the same. Which category defines yours?Startup award categories are often shaped more by founder journeys, business models, and growth approaches than by sectors alone. Through r...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Modern Diagnostic shares list at 11% premium over IPO price on BSE SME platformModern Diagnostic and Research Centre's shares are poised for a steady debut on the BSE SME, with grey market premiums indicating a 15% lis...
- Budget for 'pharmacy of the world': What Sitharaman & Co can do to make medicines more affordable in IndiaUnion Budget 2026: India's pharmaceutical landscape is on the brink of a transformative boom. To maintain this upward trajectory, the focus...
- Diagnostics company Molbio files DRHP with Sebi for an IPOMolbio Diagnostics, a Goa-based POC diagnostics company, filed its DRHP to raise Rs 200 crore via fresh issue and 1.25 crore shares through...
- Sumit Gupta remains positive on Cipla and Sun Pharma amid strong US generic market performanceSo, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the niche launches. An...
- Lightspeed may lead $50-60 million round in healthcare company Qure.aiVenture capital fund Lightspeed will lead a $50-60 million investment in Qure.ai through its growth fund. Sources said the VC fund will inv...
- Lord’s Mark Industries to raise Rs 500 crore via IPOThe company will invest the proceeds in its subsidiaries to develop medtech products, produce innovative diagnostic solutions, expand its p...
- Will redouble efforts to extend TRIPS waiver to Covid-19 diagnostics, therapeutics: GoyalAt the Voice of Global South Summit, he also said that India is open to enter into preferential trade agreements with interested countries ...
- NITI Aayog outlines a range of investment opportunities in healthcare sectorThis is on the back of an aging population, a growing middle class, the rising proportion of lifestyle diseases, an increased emphasis on p...
- Aditya Birla Sun Life Mutual Fund launches Pharma & Healthcare FundThe scheme can also invest in equities of listed overseas companies, in line with the RBI and SEBI guidelines.
- There are huge opportunities in healthcare market: Vrijesh Kasera, Mirae AMCPick your companies very prudently looking at the earnings growth visibility and the management quality.
- Exports major contributor to API revenues: Sushil Suri, Morepen LabsThe second growth which is coming from in the domestic market is from home diagnostics.
- Roche plans to roll out new drugs; plans new market access strategies in India: Maturin Tchoumi, Roche IndiaIndia is a fragmented market and has its own challenges; there is a private sector and public sector. About 80% of the healthcare expenses ...
- Cancer Genetics Inc completes BioServe India buyCancer Genetics Inc has on Monday announced completing the acquisition of the Hyderabad-based genomic services firm BioServe India which is...
- Budget 2014: Increase healthcare expenditure to 2.5% of GDPAll in all one hopes to see a Pharma friendly budget that can truly unleash the potential of this sector and take India to the next level.
- Opto Circuits acquires US-based firmBangalore-based developer and manufacturer of patient monitoring systems and interventional products, Opto Circuits, acquired US-based Unet...
- In good healthIndia's healthcare industry is valued at about $23 billion, which is almost four per cent of the GDP and is expected to grow at 12-13 per c...
Load More
